Merck's Commitment to

“Merck’s Commitment to Infectious Diseases: The Commercialization Challenges of New Antibiotics”

Brian Woolhoouse, VP and General Manager, Hospital Acute Care at Merck joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss ‘Merck’s Commitment to Infectious Diseases: The Commercialization Challenges of New Antibiotics”.

In this presentation, learn about Merck’s commitment to innovation and leadership in infectious diseases.

Download the presentation to understand more about:

  • How Merck is actively addressing the unmet need
  • Merck’s focus on antibiotic innovation and discovery across many of the most urgent threats
  • Launching Novel IV antibiotics

…and much more!

Get your copy here!

To find out more about the commercialization challenges of new antibiotics,  attend World Anti-Microbial Resistance Congress USA 2016, held September 8-9 in Washington, DC.

Attend World Anti-Microbial Resistance USA 2016

Leave a Reply

Your email address will not be published. Required fields are marked *